Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|June 30, 2022
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion ClearanceArianna Colini Baldeschi, Marco Zattoni, Silvia Vanni, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion DiseasesMatteo Staderini, Suzana Aulić, Manuela Bartolini, et al.
Frontiers in Aging Neuroscience|December 26, 2022
Semantic and right temporal variant of FTD: Next generation sequencing genetic analysis on a single-center cohortGiacomina Rossi, Erika Salvi, Elkadia Mehmeti, et al.
Nature Biotechnology|October 22, 2002
Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic miceJiri G Safar, Michael Scott, Jeff Monaghan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2006
Human prions and plasma lipoproteinsJiri G Safar, Holger Wille, Michael D Geschwind, et al.
Scientific Reports|February 12, 2016
Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-βGiuseppe Di Fede, Marcella Catania, Emanuela Maderna, et al.
Stem Cell Research & Therapy|June 15, 2025
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel deliveryAngela Marcianti, Eleonora Spampinato, Sara Nava, et al.
Journal of Medicinal Chemistry|January 23, 2026
Peptidomimetics Inspired by α-Synuclein or Its Chaperone αB-Crystallin Differentially Modulate α-Synuclein AggregationNicolo Bisi, Josine Kothuis, Julia Kaffy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 25, 2023
Combined 18F-FDG PET-CT markers in dementia with Lewy bodiesMaria Vittoria Mattoli, Fabrizio Cocciolillo, Piero Chiacchiaretta, et al.
Pageof 24